Double-blind, placebo-controlled, pilot trial of botulinum toxin a in restless legs syndrome

被引:17
|
作者
Nahab, Fatta B.
Peckham, Elizabeth L.
Hallett, Mark
机构
[1] Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD
[2] Human Motor Control Section, NINDS/NIH, Bldg 10, Bethesda, MD 20892-1428
关键词
D O I
10.1212/01.wnl.0000325994.93782.a1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:950 / 951
页数:2
相关论文
共 50 条
  • [31] Ropinirole in the treatment of patients with restless legs syndrome: A US-based randomized, double-blind, placebo-controlled clinical trial
    Bogan, RK
    Fry, JM
    Schmidt, MH
    Carson, SW
    Ritchie, SY
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (01) : 17 - 27
  • [32] Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial
    M. Padberg
    S.F.T.M. de Bruijn
    D.L.J. Tavy
    [J]. Journal of Neurology, 2007, 254 : 290 - 295
  • [33] Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study
    Øystein Grimstad
    Bjørn Øivind Kvammen
    Carl Swartling
    [J]. American Journal of Clinical Dermatology, 2020, 21 : 741 - 748
  • [34] Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study
    Grimstad, Oystein
    Kvammen, Bjorn Oivind
    Swartling, Carl
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (05) : 741 - 748
  • [35] Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial
    Padberg, M.
    de Bruijn, S. F. T. M.
    Tavy, D. L. J.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (03) : 290 - 295
  • [36] Pergolide treatment of the Restless Legs Syndrome: A double-blind placebo-controlled study with objective assessment of leg movements
    Allen, RP
    Earley, CJ
    Hening, WA
    Walters, AS
    Yaffee, J
    Wagner, ML
    [J]. NEUROLOGY, 1998, 50 (04) : A68 - A69
  • [37] EFFICACY AND TOLERABILITY OF GABAPENTIN ENACARBIL IN SUBJECTS WITH RESTLESS LEGS SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Lee, D.
    Ziman, R.
    Perkins, A.
    Poceta, J.
    Walters, A. S.
    Barrett, R. W.
    [J]. SLEEP, 2009, 32 : A300 - A300
  • [38] Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
    Simpson, DM
    Alexander, DN
    OBrien, CF
    Tagliati, M
    Aswad, AS
    Leon, JM
    Gibson, J
    Mordaunt, JM
    Monaghan, EP
    [J]. NEUROLOGY, 1996, 46 (05) : 1306 - 1310
  • [39] Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome
    Winkelman, John W.
    Jaros, Mark J.
    [J]. SLEEP MEDICINE, 2018, 48 : 1 - 7
  • [40] Ropinirole for restless legs syndrome - A placebo-controlled crossover trial
    Adler, CH
    Hauser, RA
    Sethi, K
    Caviness, JN
    Marlor, L
    Anderson, WM
    Hentz, JG
    [J]. NEUROLOGY, 2004, 62 (08) : 1405 - 1407